Re-VOLVE: Phase II clinical trial in women with ovarian cancer progressing post-PARP inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Circulating tumor DNA ...
Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells ...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results